Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-26-056100
Filing Date
2026-05-06
Accepted
2026-05-06 13:27:09
Documents
16
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tm2613401d1_10ka.htm   iXBRL 10-K/A 88821
2 EXHIBIT 31.1 tm2613401d1_ex31-1.htm EX-31.1 10840
3 EXHIBIT 31.2 tm2613401d1_ex31-2.htm EX-31.2 11663
4 EXHIBIT 32.1 tm2613401d1_ex32-1.htm EX-32.1 4524
5 EXHIBIT 32.2 tm2613401d1_ex32-2.htm EX-32.2 4557
  Complete submission text file 0001104659-26-056100.txt   402574

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA tdac-20251231.xsd EX-101.SCH 3992
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tdac-20251231_def.xml EX-101.DEF 29807
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE tdac-20251231_lab.xml EX-101.LAB 40182
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tdac-20251231_pre.xml EX-101.PRE 28028
20 EXTRACTED XBRL INSTANCE DOCUMENT tm2613401d1_10ka_htm.xml XML 9841
Mailing Address 52 E 83RD ST. NEW YORK NY 10028
Business Address 52 E 83RD ST. NEW YORK NY 10028 (413) 204-2769
Translational Development Acquisition Corp. (Filer) CIK: 0001926599 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-42451 | Film No.: 26947398
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)